TRYP THERAPEUTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0476 USD | -2.76% |
|
+32.50% | +39.88% |
| Mar. 08 | Tryp Therapeutics Inc. announced that it has received AUD 3.39 million in funding | CI |
| Feb. 05 | Tryp Therapeutics Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023 | CI |
Chart calendar Tryp Therapeutics Inc.
e4b3ce7523.KQV2cZOT33Vwi3KGJ1HhF6NjG0ZDXix4HbgbSOkP40M.fGI4QsTQllg5zwfJcyavJvoTUTwlbxorfuxSJ75amgVqfAMjyszsQD_AHQ~696b2fd1ca7fb663af29af7ef5a5e20c
Upcoming events on Tryp Therapeutics Inc.
Past events on Tryp Therapeutics Inc.
| 2024-04-25 | Q2 2024 Earnings Release (Projected) |
| 2024-03-08 10:00 am | Annual General Meeting |
| 2024-02-05 12:50 pm | Q1 2024 Earnings Release |
| 2023-12-29 06:34 pm | Q4 2023 Earnings Release |
| 2023-07-31 05:41 pm | Q3 2023 Earnings Release |
| 2023-04-28 05:46 pm | Q2 2023 Earnings Release |
| 2023-01-25 05:25 pm | Q1 2023 Earnings Release |
| 2023-01-09 02:00 pm | JP Morgan Healthcare Conference |
| 2022-12-15 02:00 pm | OTC Markets Group KCSA Mental Health Investor Conference |
| 2022-12-13 01:12 pm | FY 2022 Earnings Release |
| 2022-11-11 | Society for Neuroscience Conference |
| 2022-10-04 09:00 am | Business Update Call |
| 2022-07-28 04:38 pm | Q3 2022 Earnings Release |
| 2022-06-23 09:00 am | Annual General Meeting |
| 2022-04-29 05:50 pm | Interim 2022 Earnings Release |
| 2022-03-12 | Roth Conference |
| 2022-01-28 04:16 pm | Q1 2022 Earnings Release |
| 2022-01-11 06:30 pm | Biotech Showcase |
| 2022-01-10 07:00 am | H.C. Wainwright BioConnect Conference |
| 2022-01-09 | JP Morgan Healthcare Conference |
Annual results
| Fiscal Period | August | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million CAD | Released Forecast Spread | -7,29 -6,77 -7.64% | -7,36 -6,27 -17.43% | -5,25 -4,67 -12.37% | -5,10 |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -8,25 -7,72 -7% | -7,49 -6,27 -19.58% | -5,27 -4,61 -14.15% | -5,10 |
|
Net income Million CAD | Released Forecast Spread | -8,25 -7,72 -7% | -7,49 -6,27 -19.58% | -5,27 -4,49 -17.41% | -5,10 |
|
EPS CAD | Released Forecast Spread | -0,14 -0,13 -7.69% | -0,10 -0,10 0% | -0,05 -0,04 -25% | -0,03 |
| Announcement Date | 22/12/21 | 13/12/22 | 29/12/23 | - |
Quarterly results
| Fiscal Period | August | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | ||
|
EBIT Million CAD | Released Forecast Spread | -3,01 -3,03 0.5% | -1,55 -3,34 53.57% | -2,10 -1,01 -108.15% | -1,62 -1,65 1.92% | -1,27 -1,91 33.63% | -1,59 -1,02 -56.5% | -1,13 -1,09 -3.94% | -1,16 | -1,33 | -1,52 | ||
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -3,00 -3,02 0.71% | -1,56 -3,33 53.23% | -2,17 -1,01 -114.61% | -1,63 -1,65 0.83% | -1,29 -1,91 32.49% | -0,78 | -1,69 -1,02 -66.03% | -1,16 -1,09 -6.67% | -1,16 | -1,33 | -1,52 | |
|
Net income Million CAD | Released Forecast Spread | -3,00 -3,02 0.73% | -1,56 -3,33 53.23% | -0,75 | -2,17 -1,01 -114.61% | -1,63 -1,65 0.83% | -1,29 -1,91 32.49% | -0,66 | -1,69 -1,02 -66.03% | -1,16 -1,09 -6.67% | -1,16 | -1,33 | -1,52 |
|
EPS CAD | Released Forecast Spread | -0,05 -0,05 0% | -0,03 -0,03 0% | -0,01 | -0,03 -0,01 -200% | -0,02 -0,01 -100% | -0,01 -0,01 0% | -0,01 -0,01 0% | -0,01 -0,01 0% | -0,01 | -0,01 | -0,01 | |
| Announcement Date | 28/01/22 | 29/04/22 | 28/07/22 | 13/12/22 | 25/01/23 | 28/04/23 | 31/07/23 | 29/12/23 | 05/02/24 | - | - | - |
| 2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-05-01 06:30 am | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 2024-05-01 06:30 am | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 2024-05-01 07:00 am | ALKERMES PLC: Q1 2024 Earnings Release |
| 2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 2024-05-01 | CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for Tryp Therapeutics Inc.
| Today | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 2024-04-29 04:05 pm | QIAGEN N.V.: Q1 2024 Earnings Release |
| 2024-04-28 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-28 | SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release |
| 2024-04-28 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release |
| 2024-04-28 | MORPHOSYS AG: Q1 2024 Earnings Release |
| 2024-04-26 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-26 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-26 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 2024-04-25 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TRYP Stock
- TRYP.F Stock
- Calendar Tryp Therapeutics Inc.
